Pharmacy
Drug negotiation with manufacturers is government price fixing and is unconstitutional, groups say.
The science is there, but not the capital to get certain drugs to market. That means choices are being made, one says.
HIMSS23
When providers have conversations with patients and switch to lower-cost drugs, individuals are saving an average of $61 on prescriptions, says Dr. Andrew Mellin, CMIO at Surescripts.
Expansion eligibility for the full low-income subsidy-benefit arrives as many are losing Medicaid coverage in the redetermination process.
CMS intends to send the first invoices in 2025 to manufacturers for the rebates owed to Medicare in 2023 and 2024.
The move is an effort to expand and accelerate pharmacy care delivery for patients with chronic and complex care needs.
Two organizations protest that treatment is no more accessible than under the agency's current clinical trial policy.
The initiatives are meant to connect patients to services addressing needs such as food transportation, housing and baby supplies.
A provision in the IRA would ameliorate the out-of-pocket spending increases when people transition from commercial insurance to Part D.
HIMSS23
DrFirst's AI-driven medication algorithm can read the intent of the prescription renewal request, says CMO Dr. Colin Banas.